192 related articles for article (PubMed ID: 23538612)
1. Management of fingolimod-associated macular edema.
Chui J; Herkes GK; Chang A
JAMA Ophthalmol; 2013 May; 131(5):694-6. PubMed ID: 23538612
[No Abstract] [Full Text] [Related]
2. Fingolimod-associated macular edema: resolution by sub-tenon injection of triamcinolone with continued fingolimod use.
Minuk A; Belliveau MJ; Almeida DR; Dorrepaal SJ; Gale JS
JAMA Ophthalmol; 2013 Jun; 131(6):802-4. PubMed ID: 23599188
[No Abstract] [Full Text] [Related]
3. Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Afshar AR; Fernandes JK; Patel RD; Ksiazek SM; Sheth VS; Reder AT; Hariprasad SM
JAMA Ophthalmol; 2013 Jan; 131(1):103-7. PubMed ID: 23307220
[No Abstract] [Full Text] [Related]
4. Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis.
Zarbin MA; Jampol LM; Jager RD; Reder AT; Francis G; Collins W; Tang D; Zhang X
Ophthalmology; 2013 Jul; 120(7):1432-9. PubMed ID: 23531349
[TBL] [Abstract][Full Text] [Related]
5. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
Saab G; Almony A; Blinder KJ; Schuessler R; Brennan DC
Arch Ophthalmol; 2008 Jan; 126(1):140-1. PubMed ID: 18195237
[No Abstract] [Full Text] [Related]
6. Does fingolimod in multiple sclerosis patients cause macular edema?
Turaka K; Bryan JS
J Neurol; 2012 Feb; 259(2):386-8. PubMed ID: 22231867
[TBL] [Abstract][Full Text] [Related]
7. Fingolimod-associated macular edema: incidence, detection, and management.
Jain N; Bhatti MT
Neurology; 2012 Feb; 78(9):672-80. PubMed ID: 22371414
[TBL] [Abstract][Full Text] [Related]
8. Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safety.
Huggins A; Sergott RC
Curr Opin Ophthalmol; 2011 Nov; 22(6):447-50. PubMed ID: 21946305
[No Abstract] [Full Text] [Related]
9. Use of intraocular ketorolac tromethamine for the treatment of chronic cystoid macular edema.
Margalit E; Boysen JL; Zastrocky JP; Katz A
Can J Ophthalmol; 2010 Aug; 45(4):409-10. PubMed ID: 20648080
[No Abstract] [Full Text] [Related]
10. [Cystoid macular oedema after fingolimod treatment in multiple sclerosis].
Asensio-Sánchez VM; Trujillo-Guzmán L; Ramoa-Osorio R
Arch Soc Esp Oftalmol; 2014 Mar; 89(3):104-6. PubMed ID: 24269406
[TBL] [Abstract][Full Text] [Related]
11. Effects of fingolimod in relapsing-remitting multiple sclerosis.
Sorensen PS
Lancet Neurol; 2014 Jun; 13(6):526-7. PubMed ID: 24685277
[No Abstract] [Full Text] [Related]
12. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L; Radue EW; O'Connor P; Polman C; Hohlfeld R; Calabresi P; Selmaj K; Agoropoulou C; Leyk M; Zhang-Auberson L; Burtin P;
N Engl J Med; 2010 Feb; 362(5):387-401. PubMed ID: 20089952
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod for multiple sclerosis.
Drug Ther Bull; 2012 Feb; 50(2):18-20. PubMed ID: 22329953
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.
Yeh EA; Weinstock-Guttman B
Adv Ther; 2011 Apr; 28(4):270-8. PubMed ID: 21394595
[TBL] [Abstract][Full Text] [Related]
15. Sudden unexpected death on fingolimod.
Lindsey JW; Haden-Pinneri K; Memon NB; Buja LM
Mult Scler; 2012 Oct; 18(10):1507-8. PubMed ID: 22300970
[No Abstract] [Full Text] [Related]
16. Fingolimod-induced asthma deterioration in a patient with relapsing-remitting multiple sclerosis.
van Rossum JA; Looysen EE; Daniels JM; Killestein J
Mult Scler; 2014 Nov; 20(13):1792-3. PubMed ID: 24866203
[No Abstract] [Full Text] [Related]
17. Fingolimod for the treatment of relapsing multiple sclerosis.
Jeffery DR; Markowitz CE; Reder AT; Weinstock-Guttman B; Tobias K
Expert Rev Neurother; 2011 Feb; 11(2):165-83. PubMed ID: 21158700
[TBL] [Abstract][Full Text] [Related]
18. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
Almeida DR; Johnson D; Hollands H; Smallman D; Baxter S; Eng KT; Kratky V; ten Hove MW; Sharma S; El-Defrawy S
J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod therapy and macular hemorrhage.
Bhatti MT; Freedman SM; Mahmoud TH
J Neuroophthalmol; 2013 Dec; 33(4):370-2. PubMed ID: 23845997
[TBL] [Abstract][Full Text] [Related]
20. Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia.
Tanaka M; Park K; Tanaka K
Mult Scler; 2013 Aug; 19(9):1244-5. PubMed ID: 23322501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
